PICKUP MENU
INFORMATION
-
2022年6月17日【7月25日（月）耳鼻咽喉科・頭頸部外科医局説明会を実施します】
-
2022年6月14日7月の耳鼻咽喉科臨床講義を更新しました。
-
2022年5月20日【5月30日（月）耳鼻咽喉科・頭頸部外科医局説明会を実施します】
- Fujiwara K, Fukuda A, Morita S, Yanagi H, Hoshino K, Nakamaru Y, Furuta Y, Homma A: Psychological evaluation for patients with non-cured facial nerve palsy. Auris Nasus Larynx. 49:53-57, 2022
- Morita S, Nakamaru Y, Fukuda A, Fujiwara K, Suzuki M, Hoshino K, Honma A, Homma A: The Quantification of Extracellular Trap Cell Death-Derived Products as Diagnostic Biomarkers for Otitis Media with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Eosinophilic Otitis Media. Otol Neurotol. 43:e337-e343, 2022
- Tsushima N, Kano S, Suzuki T, Idogawa H, Yoshida D, Yasuda K, Otsuka M, Aoyama H, Homma A: Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy Eur Arch Otorhinolaryngol. 279:899-905, 2022
- Kimura S, Suzuki M, Honma A, Nakazono A, Osawa M, Nakamaru Y, Homma A: Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique. Auris Nasus Larynx. 49:67-76, 2022
- Imamura Y, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Yokota T, Okano S, Tanaka K, Onoe T, Ariizumi Y, Homma A: Systemic therapy for salivary gland malignancy: current status and future perspectives. Jpn J Clin Oncol. 52:293-302, 2022
- Ishii R, Ohkoshi A, Kiyota N, Matsuura K, Yasuda K, Imamura Y, Saito Y, Homma A; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group.：Management of elderly patients with head and neck cancer. Jpn J Clin Oncol. 52:313-321, 2022
- López F, Shah JP, Beitler JJ, Snyderman CH, Lund V, Piazza C, Mäkitie AA, Guntinas-Lichius O, Rodrigo JP, Kowalski LP, Quer M, Shaha A, Homma A, Sanabria A, Ferrarotto R, Lee AWM, Lee VHF, Rinaldo A, Ferlito A：The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours. Adv Ther. 39:2379-2397
- Mäkitie AA, Alabi RO, Orell H, Youssef O, Almangush A, Homma A, Takes RP, López F, de Bree R, Rodrigo JP, Ferlito A. Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review. Adv Ther. 39:1502-1523, 2022
- Matsumoto-Sasaki M, Simizu K, Suzuki M, Suzuki M, Kimura H, Nakamaru Y, Ito YM, Honma A(Homma A), Konno S.：Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma. J Asthma Allergy 15：187-195, 2022
- Yasumatsu R, Shimizu Y, Hanai N, Kariya S, Yokota T, Fujii T, Tsukahara K, Ando M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Nekado T, Yamada T, Homma A.: Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. Int J Clin Oncol. 27:95-104, 2022